Targeting Hypoxia, a Novel Treatment for Advanced Retinoblastoma

Abstract

Treatment with glycolytic inhibitors as adjuvants to chemotherapy has the potential to increase the efficacy of chemotherapy in advanced retinoblastoma. This approach may have benefits for children with this disease and should be further investigated.